Paired antiviral approach pushes SARS-CoV-2 toward near-complete loss of infectivity

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus responsible for causing COVID-19 disease—based on a treatment that combines two complementary approaches capable of attacking the virus simultaneously, forcing its instability and hindering its ability to adapt.